(Reuters) - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday. The Food and Drug Administration approved for sale the Dynagen Mini and Inogen Mini ICDs and the Dynagen X4 and Inogen X4 CRT-Ds, Boston Scientific said. The Mini ICDs are up to 20 percent smaller by volume and up to 24 percent thinner than rival devices from other companies, Boston Scientific said. Implantable cardioverter defibrillators treat arrhythmias by shocking a dangerously racing heartbeat back into normal rhythms.
via Health News Headlines - Yahoo News http://ift.tt/1eMH5hd
No comments:
Post a Comment